Score Breakdown
Offering Ability
60
Cash Runway—
Float Risk
37
Warrant Exposure
15
Convertible Debt
85
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 50%
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 79% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split
model est. 55%
• 50-day avg $0.03 below $1 exchange minimum
💰 Capital Raise
model 18%
• Active ATM program with $730M remaining capacity
Market Data
Market Cap$812.0K
Shares Outstanding71.63M
Float43.14M
Cash$862.8K
Debt$136.8K
Short InterestN/A
Institutional Holdings
2 institutional holders · 121.3K shares
#1
BARCLAYS PLC
106.3K shares
#2
Marex Group plc
15.0K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest20.8K
Days to Cover1.0
% of Float0.1%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
424B3
ATM
2026-05-01
8-K
8K EVENT
2026-05-01
424B3
ATM
2026-05-01
4
INSIDER TRANSACTION
2026-04-21
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual CERO Dilution Snapshot
CERo Therapeutics Holdings, Inc. (CERO) has a DilutionScore of 51/100, rated High dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $729.6M.
- Stored outstanding warrants: 159,724.
- Recent SEC activity tracked for CERO: xbrl on 2026-06-30; 424B3 on 2026-05-01; 8-K on 2026-05-01.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: